Merck & Company Inc (NYSE:MRK)
over-valued
by 9%
Website | https://www.merck.com |
Sector | Health Care |
Industry | Pharmaceuticals |
Fiscal Year End | December |
Market Cap | $278B |
Beta | 0.37 |
Dividends per share | $2.76 |
Current Price | $109.07 |
Autochartist™ Valuation | $99.00 |
Conclusion |
over-valued by -9%
|